Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epiregulin is a dendritic cell-derived EGFR ligand that maintains skin and lung fibrosis. | Sci Immunol | 2022 | 36490328 | PubTator, text mining | PubMed |
| Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer. | BMC Cancer | 2022 | 36476410 | PubTator, text mining | PubMed |
| Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing. | J Transl Med | 2022 | 36474268 | PubTator, text mining | PubMed |
| Identification and verification of immune-related biomarkers and immune infiltration in diabetic heart failure. | Front Cardiovasc Med | 2022 | 36465455 | PubTator, text mining | PubMed |
| Adherens junctions organize size-selective proteolytic hotspots critical for Notch signalling. | Nat Cell Biol | 2022 | 36456828 | PubTator, text mining | PubMed |
| DNA Methylation and Epigenetic Events Underlying Renal Cell Carcinomas. | Cureus | 2022 | 36447689 | PubTator, text mining | PubMed |
| Tumor-associated macrophages in direct contact with prostate cancer cells promote malignant proliferation and metastasis through NOTCH1 pathway. | Int J Biol Sci | 2022 | 36439868 | PubTator, text mining | PubMed |
| Ovarian cancer stem cells: Critical roles in anti-tumor immunity. | Front Genet | 2022 | 36437919 | PubTator, text mining | PubMed |
| Advances in neovascularization after diabetic ischemia. | World J Diabetes | 2022 | 36437864 | PubTator, text mining | PubMed |
| Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. | Infect Agent Cancer | 2022 | 36437456 | PubTator, text mining | PubMed |
| Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. | Pharmaceutics | 2022 | 36432631 | PubTator, text mining | PubMed |
| Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost. | Int J Mol Sci | 2022 | 36430599 | PubTator, text mining | PubMed |
| JAG1 Intracellular Domain Enhances AR Expression and Signaling and Promotes Stem-like Properties in Prostate Cancer Cells. | Cancers (Basel) | 2022 | 36428807 | PubTator, text mining | PubMed |
| Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. | Cancers (Basel) | 2022 | 36428773 | PubTator, text mining | PubMed |
| Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features. | Curr Oncol | 2022 | 36421334 | PubTator, text mining | PubMed |
| The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors. | Cell Commun Signal | 2022 | 36419156 | PubTator, text mining | PubMed |
| Development of therapeutic antibodies for the treatment of diseases. | Mol Biomed | 2022 | 36418786 | PubTator, text mining | PubMed |
| Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma. | PLoS One | 2022 | 36417422 | PubTator, text mining | PubMed |
| Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development. | Stem Cells Transl Med | 2022 | 36398586 | PubTator, text mining | PubMed |
| Current landscape and future directions of bispecific antibodies in cancer immunotherapy. | Front Immunol | 2022 | 36389699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=38